Terex (TEX) - 2025 Q3 - Earnings Call Presentation
2025-10-30 12:30
Q3 2025 Earnings Presentation October 30, 2025 Forward Looking Statements Certain information in this presentation includes forward-looking statements (within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934 (the "Exchange Act") and the Private Securities Litigation Reform Act of 1995) regarding future events or our future financial performance that involve certain contingencies and uncertainties, including those discussed in our Annual Report on F ...
Intercontinental Exchange(ICE) - 2025 Q3 - Earnings Call Presentation
2025-10-30 12:30
Financial Performance Highlights - ICE achieved record 3Q25 net revenues of $2411 million, a 2% increase compared to $2349 million in 3Q24[6] - Recurring revenues reached $1275 million, representing a 5% increase[6] - Adjusted diluted EPS increased by 10% to $171[6] - Adjusted free cash flow year-to-date reached $3178 million, a 21% increase[6] Segment Performance - Exchanges segment net revenues totaled $1265 million, a 1% increase[9] - Fixed Income & Data Services revenues increased by 5% to $618 million[12] - Mortgage Technology segment revenues grew by 4% to $528 million[15] Key Growth Drivers - Data & connectivity services revenues within the Exchanges segment increased by 9%[9] - Data & network technology revenues within Fixed Income & Data Services grew by 10%[13] - Transaction revenues in Mortgage Technology increased by 12%[17] Capital Management - $674 million was returned to stockholders in 3Q25, including ~$400 million in share repurchases[8] - Ending 3Q25 leverage was approximately 29x[8] 2025 Guidance - FY25 adjusted expenses are expected to be between $3933 billion and $3943 billion[24]
Perimeter Solutions(PRM) - 2025 Q3 - Earnings Call Presentation
2025-10-30 12:30
Financial Performance - Q3 2025 - Consolidated revenue increased by 9% year-over-year, from $288417 thousand in Q3 2024 to $315443 thousand in Q3 2025[22] - Consolidated Adjusted EBITDA also increased by 9% year-over-year, from $170376 thousand to $186317 thousand[22] - Fire Safety revenue increased by 9% year-over-year, from $251845 thousand to $273384 thousand, with Adjusted EBITDA increasing by 13% from $157479 thousand to $177210 thousand[22] - Specialty Products revenue increased by 15% year-over-year, from $36572 thousand to $42059 thousand, but Adjusted EBITDA decreased by 29% from $12897 thousand to $9107 thousand[22] Financial Performance - Year-to-Date (YTD) 2025 - Consolidated revenue increased by 16% year-over-year, from $474737 thousand to $550112 thousand[22] - Consolidated Adjusted EBITDA increased by 20% year-over-year, from $247420 thousand to $295738 thousand[22] - Fire Safety revenue increased by 15% year-over-year, from $375538 thousand to $430831 thousand, with Adjusted EBITDA increasing by 24% from $212877 thousand to $264954 thousand[22] - Specialty Products revenue increased by 20% year-over-year, from $99199 thousand to $119281 thousand, but Adjusted EBITDA decreased by 11% from $34543 thousand to $30784 thousand[22] Capital Structure and Allocation - The company has approximately 1479 million basic shares outstanding[28] - Net debt to LTM Adjusted EBITDA is 10, with net debt at $334353 thousand and LTM Adjusted EBITDA at $328612 thousand[40] - Cash and cash equivalents totaled $3406 million as of Q3 2025[29]
LXP(LXP) - 2025 Q3 - Earnings Call Presentation
2025-10-30 12:30
Portfolio Overview - LXP Industrial Trust has gross assets of $4.8 billion and owns 112 properties [7] - The stabilized portfolio is 96.8% leased [12, 17] - 48% of the tenancy is investment grade [9] - The portfolio's weighted average lease term (WALT) is 4.9 years [17] Financial Performance - The company generated Adjusted Company FFO of $0.16 per share in the third quarter [12] - Same-store NOI growth was 4% year-to-date and 2% in the quarter [12] - The company repaid $140 million of outstanding 6.75% Senior Notes due 2028 [12] - Net Debt to Adjusted EBITDA was reduced to 5.2x [12, 13] Growth Opportunities - Approximately 64% of the portfolio is expiring through 2030, with current mark-to-market on rents estimated to be approximately 17% [15, 64] - The average annual rental escalations are 2.9% [15, 60] - The company has 1.8 million square feet of first and second-generation space available for lease [15, 60] Strategic Initiatives - The company sold two vacant development projects totaling 2.1 million square feet for $175 million, representing a 20% premium over the gross book value [12] - The company acquired one property for $30 million at a cash capitalization rate of 6.5% [12] - The company announced a reverse stock split of common shares at a ratio of 1-for-5 [12]
Alnylam Pharmaceuticals(ALNY) - 2025 Q3 - Earnings Call Presentation
2025-10-30 12:30
Financial Performance - Total net product revenues reached $851 million in Q3 2025, representing a 103% year-over-year growth compared to Q3 2024[17, 24] - Total TTR net revenues were $724 million in Q3 2025, a 135% increase year-over-year[17, 31] - U S total TTR net revenues amounted to $543 million in Q3 2025, demonstrating a 194% year-over-year growth[17] - The company increased its 2025 total net product revenue guidance to a range of $2950 million to $3050 million, a 10% increase at the midpoint[17] - Non-GAAP operating income was $476 million, resulting in a 38% non-GAAP operating margin[65] Product Performance - Rare disease franchise revenues totaled $127 million in Q3 2025, a 14% increase year-over-year[28] - OXLUMO sales grew by 31% year-over-year, driven by a 15% increase in global patients on therapy[29] - AMVUTTRA's ATTR-CM launch contributed significantly to growth, with estimated ATTR-CM revenue of approximately $300 million in Q3 2025 in the U S [33, 34] Pipeline and Clinical Development - Phase 3 trial initiated for nucresiran in ATTR-CM, with topline results expected in 2028 and targeting launch around 2030[17, 47] - Phase 3 cardiovascular outcomes trial (CVOT) initiated for zilebesiran in high cardiovascular risk patients with uncontrolled hypertension, randomizing approximately 11,000 patients[17, 56] - HELIOS-B data showed a 37% risk reduction in time-to-first ACM and CV events with long-term vutrisiran treatment[43]
Omnicell(OMCL) - 2025 Q3 - Earnings Call Presentation
2025-10-30 12:30
Company Strategy & Vision - Omnicell's growth strategy focuses on connecting the health network, disrupting pharmacy care with innovation, and growing where care is delivered[12] - The company aims to transform pharmacy care through outcomes-centric solutions, combining robotics, software, expert services, and analytics[13] - Omnicell is executing on its goal to advance the industry-defined vision of the Autonomous Pharmacy[30] Financial Performance & Metrics - Q3 2025 total revenues reached $311 million, a 10% year-over-year increase[71] - Non-GAAP gross margin for Q3 2025 was 442%, a decrease of 30 basis points year-over-year[71] - Non-GAAP operating expenses for Q3 2025 were $110 million, a 9% increase year-over-year[71] - Non-GAAP EBITDA for Q3 2025 was $41 million, a 6% increase year-over-year[71] - Non-GAAP diluted earnings per share for Q3 2025 were $051, a decrease of $005 year-over-year[71] - The company projects total year 2025 revenue between $1177 billion and $1187 billion, a 6% year-over-year change at the midpoint[72] - The company projects product bookings between $500 million and $550 million for TY-2025[78] - The company projects annual recurring revenue (ARR) between $610 million and $630 million for TY-2025[78] Recurring Revenue & SaaS - SaaS and Expert Services are projected to be 22% of total revenue in 2025[9, 27]
LCI Industries(LCII) - 2025 Q3 - Earnings Call Presentation
2025-10-30 12:30
Financial Performance Highlights - Net sales reached $1 billion, a 13% year-over-year increase[11] - Net income was $62 million, representing 6% of net sales, a 75% year-over-year increase[11] - Adjusted EBITDA was $106 million, or 10.2% of net sales, a 24% year-over-year increase[11] - The company returned $215 million of capital to shareholders through dividends and strategic share buybacks year-to-date through Q3[12,50] Operational Performance and Market Trends - North American wholesale towable unit shipments were 65,700 in Q3 2025, a 4% year-over-year decrease[18] - North American retail towable units sold were estimated at 88,900 in Q3 2025, a 1% year-over-year increase[18] - Q3 2025 RV OEM sales increased by 11% year-over-year, driven by price increases related to tariffs, increased mix in higher-content fifth wheels, market share gains, and an increase in North American motorhome RV unit shipments[18] - Adjacent Industries sales increased by 22% year-over-year, primarily due to recent acquisitions in the resilient bus market and higher sales to North American utility trailer and marine OEMs[27] - Aftermarket sales increased by 7% year-over-year, driven by product innovations and the expanding Camping World relationship within the RV aftermarket[32] Strategic Initiatives and Outlook - The company projects approximately $380 million in consolidated net sales for October 2025, a 15% year-over-year increase[57] - The company is targeting 8 to 10 facility consolidations in 2026 after 5 in 2025[63] - The company is exploring divestiture opportunities in 2026 of approximately $75 million of revenues that are dilutive to the business[63]
Ranpak (PACK) - 2025 Q3 - Earnings Call Presentation
2025-10-30 12:30
Financial Performance - Net revenue increased by 80% compared to the prior year, or 44% on a constant currency basis[15] - Global sales of automation equipment increased by 630% compared to the prior year, or 562% on a constant currency basis[15] - Adjusted EBITDA increased by 81% (35% on a constant currency basis), including a 400 bps non-cash headwind for the provision of warrants in revenue ($08 million)[15] - Gross margin decreased by 28% year-over-year to 345% (344% on a constant currency basis) due to increased production costs and product mix[15] - Year-to-date net revenue increased by 56% on a constant currency basis[29] - Year-to-date Adjusted EBITDA decreased by 78% on a constant currency basis[29] Regional Performance - North America revenue increased by 109% due to increased volumes from e-commerce activity among large enterprise accounts[15] - EMEA/APAC revenue increased by 58% (decreased 06% on a constant currency basis) driven by increased automation equipment sales and stronger Euro to USD exchange rates[15] - Volumes in Europe/APAC were down by 25% due to a challenging environment and uncertainty from tariffs and de-stocking in APAC[17] Strategic Agreements - Agreement with Walmart is anticipated to be transformative to Automation and implies, based on expectations and current paper pricing, potential spend of $700 million over 10 years, to achieve full vesting[22] - Potential spend for maximum vesting with Amazon is $400 million excluding the cost of paper related to pre-existing NOAM business lines[32]
EPR Properties(EPR) - 2025 Q3 - Earnings Call Presentation
2025-10-30 12:30
Portfolio & Investment - Total portfolio investments stand at approximately $6.9 billion[11], spread across 330 properties[11] - Experiential portfolio accounts for roughly $6.5 billion, representing 94% of total investments[12] - Q3 investment spending reached $54.5 million[11], bringing the year-to-date total to $140.8 million[29] - The company anticipates disposition proceeds between $150 million and $160 million for 2025[33] Financial Performance - Total revenue for Q3 2025 was $182.3 million, a 1% increase compared to $180.5 million in Q3 2024[41] - Net income attributable to common shareholders for Q3 2025 increased by 49.3% to $60.6 million, compared to $40.6 million in Q3 2024[41] - For the nine months ended September 30, 2025, total revenue was $535.4 million, a 2.8% increase from $520.8 million in the same period of 2024[44] - Net income attributable to common shareholders for the nine months ended September 30, 2025, increased by 39.2% to $189.9 million, compared to $136.4 million in the same period of 2024[44] Guidance - The company revised its FFO as adjusted per share guidance to $5.05-$5.13[53] - Investment spending guidance remains between $225 million and $275 million[53]
Roblox(RBLX) - 2025 Q3 - Earnings Call Presentation
2025-10-30 12:30
Q3 2025 Results - Revenue reached $1.4 billion, a 48% year-over-year growth[5] - Bookings totaled $1.9 billion, showing a 70% year-over-year increase[5] - Average Daily Active Users (DAUs) were 151.5 million, up 70% year-over-year[5] - Hours Engaged reached 39.6 billion, a significant 91% year-over-year growth[5] - Net loss was $(257) million, a 121% year-over-year growth[7] - Net cash provided by operating activities was $546 million[7] - Free cash flow was $443 million, a 103% year-over-year growth[7] - Adjusted EBITDA was $46 million[7] Q4 and Fiscal Year 2025 Guidance - Q4 2025 revenue is projected between $1.35 billion and $1.4 billion, representing a 37% to 42% year-over-year increase[57] - Q4 2025 bookings are expected to be between $2 billion and $2.05 billion, a 47% to 51% year-over-year increase[57] - Fiscal year 2025 revenue is guided between $4.8255 billion and $4.8755 billion, a 34% to 35% year-over-year increase[58] - Fiscal year 2025 bookings are projected between $6.5662 billion and $6.6162 billion, a 50% to 51% year-over-year increase[58]